COSMAI, LAURA
COSMAI, LAURA
Acute Kidney Injury in Cancer Patients
2018-01-01 Gallieni, Maurizio; Cosmai, Laura; Porta, Camillo
Editorial Comment from Dr Porta et al. to Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA
2017-01-01 Porta, CAMILLO GUGLIELMO GIUSEPPE; Previtali, Pietro; Cosmai, Laura
Glomerular diseases and cancer: evaluation of underlying malignancy
2016-01-01 Pani, A.; Porta, C.; Cosmai, L.; Melis, P.; Floris, M.; Piras, D.; Gallieni, M.; Rosner, M.; Ponticelli, C.
Harmonization of renal function assessment is needed throughout the whole process of anticancer drug development
2016-01-01 Porta, C.; Cosmai, L.; Gallieni, M.; Perazella, M. A.
Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature
2019-01-01 Vitale, M. G.; Baldessari, C.; Milella, M.; Buti, S.; Militello, A. M.; Di Girolamo, S.; Fornarini, G.; Perri, G.; Basso, U.; Maruzzo, M.; Porta, C.; Cosmai, L.; Pipitone, S.; Cerma, K.; Cascinu, S.; Sabbatini, R.
Intermittent hemodiafiltration in refractory congestive heart failure: bnp and balance of inflammatory cytokines
2007-01-01 Libetta, Carmelo; Sepe, V; Zucchi, Manuela; Pisacco, Patrizia; Cosmai, Laura; Meloni, Federica; Campana, Claudia; Rampino, T; Monti, MARIA CRISTINA; Tavazzi, L; Dal Canton, A.
Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines
2019-01-01 Frascà, Giovanni M.; Brigante, Fabiana; Volpe, Alessandro; Cosmai, Laura; Gallieni, Maurizio; Porta, Camillo
Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM)
2019-01-01 Giuseppa Vitale, M.; Bracarda, S.; Cosmai, L.; Crocetti, E.; Di Lorenzo, G.; Lapini, A.; Mandressi, A.; Martorana, G.; Masini, C.; Montironi, R.; Ortega, C.; Passalacqua, R.; Porta, C.; Procopio, G.; Sepe, P.; Romano, Lorenzo; Luigi Pappagallo, G.; Conti, G.; Guida, M.; Martignoni, G.; Nole, F.; Pignata, S.; Gori, S.; Carteni, G.
Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa’ Italiana di Nefrologia (SIN) multidisciplinary consensus position paper
2019-01-01 Silvestris, N.; Argentiero, A.; Cosmai, L.; Porta, C.; Gesualdo, L.; Brunori, G.; Brunetti, O.; Rampino, T.; Secondino, S.; Rizzo, G.; Pedrazzoli, P.
Opening an onconephrology clinic: recommendations and basic requirements
2018-01-01 Cosmai, Laura; Porta, Camillo; Perazella, Mark A.; Launay-Vacher, Vincent; Rosner, Mitchell H.; Jhaveri, Kenar D.; Floris, Matteo; Pani, Antonello; Teuma, Cécile; Szczylik, Cèzary A; Gallieni, Maurizio
Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: A systematic review and meta-analysis
2019-01-01 Nunno, V. D.; Mollica, V.; Gatto, L.; Santoni, M.; Cosmai, L.; Porta, C.; Massari, F.
Renal cancer in kidney transplanted patients
2015-01-01 Frasca, G. M.; Sandrini, S.; Cosmai, L.; Porta, C.; Asch, W.; Santoni, M.; Salviani, C.; D'Errico, A.; Malvi, D.; Balestra, E.; Gallieni, M.
Renal effects of targeted anticancer therapies
2015-01-01 Porta, C.; Cosmai, L.; Gallieni, M.; Pedrazzoli, P.; Malberti, F.
Renal toxicity of anticancer agents targeting HER2 and EGFR
2015-01-01 Cosmai, L.; Gallieni, M.; Porta, C
Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs)
2017-01-01 Cosmai, L.; Gallieni, M.; Liguigli, W.; Porta, C.
Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysis
2015-01-01 Guida, A.; Masini, C.; Milella, M.; Di Lorenzo, G.; Santoni, M.; Prati, V.; Porta, C.; Cosmai, L.; Donati, D.; Del Giovane, C.; Mighali, P.; Sabbatini, R.
Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy
2018-01-01 Massari, Francesco; Di Nunno, Vincenzo; Gatto, Lidia; Santoni, Matteo; Schiavina, Riccardo; Cosmai, Laura; Brunocilla, Eugenio; Ardizzoni, Andrea; Porta, Camillo
Single nucleotide polymorphisms in angiogenesis-related genes and outcomes from antiangiogenic therapies in renal cell carcinoma: really a step towards personalized oncology, or not at all?
2019-01-01 Porta, Camillo; Cosmai, Laura; Rizzo, Mimma; Melazzini, Mario
The adjuvant treatment of kidney cancer: a multidisciplinary outlook
2019-01-01 Porta, C.; Cosmai, L.; Leibovich, B. C.; Powles, T.; Gallieni, M.; Bex, A.
Transplantation of kidneys with tumors
2016-01-01 Frasca, G. M.; D'Errico, A.; Malvi, D.; Porta, C.; Cosmai, L.; Santoni, M.; Sandrini, S.; Salviani, C.; Gallieni, M.; Balestra, E.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Acute Kidney Injury in Cancer Patients | 1-gen-2018 | Gallieni, Maurizio; Cosmai, Laura; Porta, Camillo | |
| Editorial Comment from Dr Porta et al. to Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA | 1-gen-2017 | Porta, CAMILLO GUGLIELMO GIUSEPPE; Previtali, Pietro; Cosmai, Laura | |
| Glomerular diseases and cancer: evaluation of underlying malignancy | 1-gen-2016 | Pani, A.; Porta, C.; Cosmai, L.; Melis, P.; Floris, M.; Piras, D.; Gallieni, M.; Rosner, M.; Ponticelli, C. | |
| Harmonization of renal function assessment is needed throughout the whole process of anticancer drug development | 1-gen-2016 | Porta, C.; Cosmai, L.; Gallieni, M.; Perazella, M. A. | |
| Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature | 1-gen-2019 | Vitale, M. G.; Baldessari, C.; Milella, M.; Buti, S.; Militello, A. M.; Di Girolamo, S.; Fornarini, G.; Perri, G.; Basso, U.; Maruzzo, M.; Porta, C.; Cosmai, L.; Pipitone, S.; Cerma, K.; Cascinu, S.; Sabbatini, R. | |
| Intermittent hemodiafiltration in refractory congestive heart failure: bnp and balance of inflammatory cytokines | 1-gen-2007 | Libetta, Carmelo; Sepe, V; Zucchi, Manuela; Pisacco, Patrizia; Cosmai, Laura; Meloni, Federica; Campana, Claudia; Rampino, T; Monti, MARIA CRISTINA; Tavazzi, L; Dal Canton, A. | |
| Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines | 1-gen-2019 | Frascà, Giovanni M.; Brigante, Fabiana; Volpe, Alessandro; Cosmai, Laura; Gallieni, Maurizio; Porta, Camillo | |
| Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM) | 1-gen-2019 | Giuseppa Vitale, M.; Bracarda, S.; Cosmai, L.; Crocetti, E.; Di Lorenzo, G.; Lapini, A.; Mandressi, A.; Martorana, G.; Masini, C.; Montironi, R.; Ortega, C.; Passalacqua, R.; Porta, C.; Procopio, G.; Sepe, P.; Romano, Lorenzo; Luigi Pappagallo, G.; Conti, G.; Guida, M.; Martignoni, G.; Nole, F.; Pignata, S.; Gori, S.; Carteni, G. | |
| Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa’ Italiana di Nefrologia (SIN) multidisciplinary consensus position paper | 1-gen-2019 | Silvestris, N.; Argentiero, A.; Cosmai, L.; Porta, C.; Gesualdo, L.; Brunori, G.; Brunetti, O.; Rampino, T.; Secondino, S.; Rizzo, G.; Pedrazzoli, P. | |
| Opening an onconephrology clinic: recommendations and basic requirements | 1-gen-2018 | Cosmai, Laura; Porta, Camillo; Perazella, Mark A.; Launay-Vacher, Vincent; Rosner, Mitchell H.; Jhaveri, Kenar D.; Floris, Matteo; Pani, Antonello; Teuma, Cécile; Szczylik, Cèzary A; Gallieni, Maurizio | |
| Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: A systematic review and meta-analysis | 1-gen-2019 | Nunno, V. D.; Mollica, V.; Gatto, L.; Santoni, M.; Cosmai, L.; Porta, C.; Massari, F. | |
| Renal cancer in kidney transplanted patients | 1-gen-2015 | Frasca, G. M.; Sandrini, S.; Cosmai, L.; Porta, C.; Asch, W.; Santoni, M.; Salviani, C.; D'Errico, A.; Malvi, D.; Balestra, E.; Gallieni, M. | |
| Renal effects of targeted anticancer therapies | 1-gen-2015 | Porta, C.; Cosmai, L.; Gallieni, M.; Pedrazzoli, P.; Malberti, F. | |
| Renal toxicity of anticancer agents targeting HER2 and EGFR | 1-gen-2015 | Cosmai, L.; Gallieni, M.; Porta, C | |
| Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs) | 1-gen-2017 | Cosmai, L.; Gallieni, M.; Liguigli, W.; Porta, C. | |
| Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysis | 1-gen-2015 | Guida, A.; Masini, C.; Milella, M.; Di Lorenzo, G.; Santoni, M.; Prati, V.; Porta, C.; Cosmai, L.; Donati, D.; Del Giovane, C.; Mighali, P.; Sabbatini, R. | |
| Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy | 1-gen-2018 | Massari, Francesco; Di Nunno, Vincenzo; Gatto, Lidia; Santoni, Matteo; Schiavina, Riccardo; Cosmai, Laura; Brunocilla, Eugenio; Ardizzoni, Andrea; Porta, Camillo | |
| Single nucleotide polymorphisms in angiogenesis-related genes and outcomes from antiangiogenic therapies in renal cell carcinoma: really a step towards personalized oncology, or not at all? | 1-gen-2019 | Porta, Camillo; Cosmai, Laura; Rizzo, Mimma; Melazzini, Mario | |
| The adjuvant treatment of kidney cancer: a multidisciplinary outlook | 1-gen-2019 | Porta, C.; Cosmai, L.; Leibovich, B. C.; Powles, T.; Gallieni, M.; Bex, A. | |
| Transplantation of kidneys with tumors | 1-gen-2016 | Frasca, G. M.; D'Errico, A.; Malvi, D.; Porta, C.; Cosmai, L.; Santoni, M.; Sandrini, S.; Salviani, C.; Gallieni, M.; Balestra, E. |